Andreas K.
- Country
- Germany
- Department
- Derma Studien
Research Overview
- Phase 3 Randomized Double‑Blind Placebo‑Controlled Study of Oral Enpatoran in Adults With Active Cutaneous Lupus Erythematosus (with or without systemic disease)
- Efficacy and Safety Evaluation of SAR444656 in Adults with Moderate to Severe Atopic Dermatitis: A Multinational, Double-Blind, Placebo-Controlled Phase 2 Study
- Evaluation of Briquilimab Safety and Pharmacokinetics in Adults with Chronic Spontaneous Urticaria Unresponsive to H1 Antihistamines or Omalizumab
Data & Insights
Has run more than one trial at 183 of 414 partner sites.
Specializations
Dermatological Autoimmune Conditions
Specializes in investigating treatments for cutaneous lupus erythematosus, including both subacute and chronic forms. Has extensive experience with bullous pemphigoid therapeutic approaches.
- Subacute Cutaneous Lupus
- Chronic Cutaneous Lupus
- Antimalarial-Refractory Cases
Focuses on innovative therapeutic solutions for patients with refractory conditions.
Inflammatory Skin Disorders
Conducts research in moderate to severe plaque psoriasis and atopic dermatitis. Has particular interest in developing treatments for patients with inadequate response to conventional therapies.
- Plaque Psoriasis Management
- Atopic Dermatitis Treatment
- Hidradenitis Suppurativa
Evaluates novel therapeutic approaches for chronic inflammatory skin conditions.
Urticaria and Pruritic Conditions
Investigates treatments for chronic spontaneous urticaria and chronic inducible urticaria. Additionally studies therapeutic approaches for prurigo nodularis.
- Antihistamine-Refractory Urticaria
- Dermographism
- Cold Urticaria
Specializes in managing complex cases of urticaria and pruritic disorders.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.